Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Kaj Blennow

Professor/ chief physician

Kaj Blennow
Professor/ chief physician
kaj.blennow@clinchem.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Laborativ neurovetenskap , Göteborg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

About Kaj Blennow

Latest publications

Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
Anna Antonell, Adrià Tort-Merino, José Ríos, Mircea Balasa, Sergi Borrego-Écija et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, Journal article 2019
Journal article

CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults.
Nathalie Bodd Halaas, Kristi Henjum, Kaj Blennow, Shams Dakhil, Ane-Victoria Idland et al.
Cerebral cortex (New York, N.Y. : 1991), Journal article 2019
Journal article

Postoperative delirium is associated with increased plasma neurofilament light.
Cameron P Casey, Heidi Lindroth, Rosaleena Mohanty, Zahra Farahbakhsh, Tyler Ballweg et al.
Brain : a journal of neurology, Journal article 2019
Journal article

Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
Enrica Cavedo, Simone Lista, Marion Houot, Andrea Vergallo, Michel J Grothe et al.
Neurology, Journal article 2019
Journal article

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers.
Nicholas Ashton, Marc Suarez-Calvet, Amanda Heslegrave, Abdul Hye, Cristina Razquin et al.
Alzheimer's research & therapy, Journal article 2019
Journal article

The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid.
Laura Kranaster, Carolin Hoyer, Sonani Mindt, Michael Neumaier, Norbert Müller et al.
European archives of psychiatry and clinical neuroscience, Journal article 2019
Journal article

Showing 1031 - 1040 of 1135

2006

Low serum potassium in mid life associated with decreased cerebrospinal fluid A beta 42 in late life
Michelle M. Mielke, Peter P. Zandi, Kaj Blennow, Deborah Gustafson, Magnus Sjögren et al.
ALZHEIMER DISEASE AND ASSOCIATED DISORDERS, Journal article 2006
Journal article

Tau and Amyloid Beta Protein in The CSF As Diagnostic markers for Alzheimer disease
N Andreasen, Kaj Blennow
The Shadow Line from Normal Ageing to Dementia: Clinical, Genetic and Ethical Aspects , Conference paper 2006
Conference paper

CSF Biomarkers for Alzheimer’s Disease
Deborah Gustafson, Kaj Blennow
Research advances in Alzheimer’s disease and related disorders. Vol 11. Eds. Iqbal K, Winblad B. Alzheimer’s Association , Conference paper 2006
Conference paper

RNA interference: applications in research on amyloidogenesis in Alzheimer's disease
Henrik Zetterberg, Kaj Blennow, W Xia
Trends in RNA Res. Ed. PA McNamara, New York, Nova Science Publishers, Chapter in book 2006
Chapter in book

Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.
Hugo Vanderstichele, Karen De Vreese, Kaj Blennow, Niels Andreasen, Christian Sindic et al.
Clinical chemistry and laboratory medicine : CCLM / FESCC, Journal article 2006
Journal article

Alzheimer's disease.
Kaj Blennow, Mony J de Leon, Henrik Zetterberg
Lancet, Review article 2006
Review article

Showing 1031 - 1040 of 1135

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?